Benjamin Burnett
Stock Analyst at Stifel
(2.13)
# 2,740
Out of 4,711 analysts
66
Total ratings
41.3%
Success rate
-3.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RPTX Repare Therapeutics | Maintains: Buy | $9 → $4 | $1.32 | +203.03% | 5 | Dec 13, 2024 | |
| IRON Disc Medicine | Maintains: Buy | $79 → $90 | $64.50 | +39.53% | 6 | Dec 10, 2024 | |
| ACLX Arcellx | Maintains: Buy | $83 → $122 | $75.54 | +61.50% | 5 | Oct 18, 2024 | |
| BEAM Beam Therapeutics | Maintains: Buy | $66 → $69 | $29.01 | +137.85% | 2 | Sep 11, 2024 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $63 → $68 | $25.61 | +165.52% | 7 | Sep 10, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Hold | $60 → $59 | $40.72 | +44.89% | 5 | Aug 6, 2024 | |
| PGEN Precigen | Maintains: Buy | $7 → $10 | $0.76 | +1,211.30% | 3 | Jun 3, 2024 | |
| ALLO Allogene Therapeutics | Maintains: Hold | $4.4 → $4.6 | $1.87 | +145.99% | 5 | May 14, 2024 | |
| ATRA Atara Biotherapeutics | Maintains: Hold | $120 → $58 | $11.40 | +404.39% | 4 | Apr 1, 2024 | |
| RVMD Revolution Medicines | Maintains: Buy | $37 → $47 | $44.06 | +6.67% | 3 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $7.38 | +238.75% | 11 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5.3 → $5 | $1.68 | +197.62% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $690 → $780 | $4.72 | +16,425.42% | 2 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $24 | $0.93 | +2,485.37% | 2 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $16 | $2.47 | +547.77% | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1,880 → $1,400 | $8.50 | +16,370.59% | 3 | Mar 27, 2020 |
Repare Therapeutics
Dec 13, 2024
Maintains: Buy
Price Target: $9 → $4
Current: $1.32
Upside: +203.03%
Disc Medicine
Dec 10, 2024
Maintains: Buy
Price Target: $79 → $90
Current: $64.50
Upside: +39.53%
Arcellx
Oct 18, 2024
Maintains: Buy
Price Target: $83 → $122
Current: $75.54
Upside: +61.50%
Beam Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $66 → $69
Current: $29.01
Upside: +137.85%
IDEAYA Biosciences
Sep 10, 2024
Maintains: Buy
Price Target: $63 → $68
Current: $25.61
Upside: +165.52%
CRISPR Therapeutics AG
Aug 6, 2024
Maintains: Hold
Price Target: $60 → $59
Current: $40.72
Upside: +44.89%
Precigen
Jun 3, 2024
Maintains: Buy
Price Target: $7 → $10
Current: $0.76
Upside: +1,211.30%
Allogene Therapeutics
May 14, 2024
Maintains: Hold
Price Target: $4.4 → $4.6
Current: $1.87
Upside: +145.99%
Atara Biotherapeutics
Apr 1, 2024
Maintains: Hold
Price Target: $120 → $58
Current: $11.40
Upside: +404.39%
Revolution Medicines
Sep 21, 2023
Maintains: Buy
Price Target: $37 → $47
Current: $44.06
Upside: +6.67%
Sep 15, 2023
Reiterates: Buy
Price Target: $25
Current: $7.38
Upside: +238.75%
May 4, 2023
Maintains: Hold
Price Target: $5.3 → $5
Current: $1.68
Upside: +197.62%
Sep 10, 2021
Maintains: Buy
Price Target: $690 → $780
Current: $4.72
Upside: +16,425.42%
Jun 28, 2021
Upgrades: Buy
Price Target: $22 → $24
Current: $0.93
Upside: +2,485.37%
Jan 6, 2021
Initiates: Hold
Price Target: $16
Current: $2.47
Upside: +547.77%
Mar 27, 2020
Upgrades: Buy
Price Target: $1,880 → $1,400
Current: $8.50
Upside: +16,370.59%